<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/65CA66B5-6FE8-4FD7-9233-FBCF31BFD4B2"><gtr:id>65CA66B5-6FE8-4FD7-9233-FBCF31BFD4B2</gtr:id><gtr:name>Cornell University</gtr:name><gtr:address><gtr:line1>410 Thurston Ave</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AB1073B7-08FD-4FC2-91A7-7E8C3978C87A"><gtr:id>AB1073B7-08FD-4FC2-91A7-7E8C3978C87A</gtr:id><gtr:name>Nijmegen Centre for Mitochondrial Disorders (NCMD)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/65CA66B5-6FE8-4FD7-9233-FBCF31BFD4B2"><gtr:id>65CA66B5-6FE8-4FD7-9233-FBCF31BFD4B2</gtr:id><gtr:name>Cornell University</gtr:name><gtr:address><gtr:line1>410 Thurston Ave</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB1073B7-08FD-4FC2-91A7-7E8C3978C87A"><gtr:id>AB1073B7-08FD-4FC2-91A7-7E8C3978C87A</gtr:id><gtr:name>Nijmegen Centre for Mitochondrial Disorders (NCMD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/424B92BB-7449-42E2-B5E7-796EC47BD26C"><gtr:id>424B92BB-7449-42E2-B5E7-796EC47BD26C</gtr:id><gtr:firstName>Alexander</gtr:firstName><gtr:surname>Galkin</gtr:surname><gtr:orcidId>0000-0001-8469-2283</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1100051"><gtr:id>5FE6F477-05F2-4980-894F-0A9EF0D381B5</gtr:id><gtr:title>Role of mitochondrial Complex I in cellular response to hypoxia</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1100051</gtr:grantReference><gtr:abstractText>Where there?s life, there is energy. In our body energy is generated by mitochondria often referred as power stations of the cell. Most of the oxygen from the air we breathe is consumed by mitochondria to produce energy during the process called cellular respiration. This energy is used for many needs of the body such as heart beating, brain activity, kidney functioning as well as synthesis of proteins and DNA inside all our cells. Hypoxia is a lack of oxygen in the body or any organ and can damage cells and tissues. Hypoxia can be caused by many factors, including disease, pathology or trauma and it also occurs during heart surgery. Usually, hypoxia is followed by restoration of oxygen supply (reoxygenation), which makes the damage greater and in some cases irreversible. Mitochondria are responsible for that damage, when they form toxic agents known as free radicals. Enzyme called Complex I is the most important and least understood key component of the mitochondria and it initiates the processes of energy production during respiration of the cell. We have recently found that Complex I is very important in hypoxia/reoxygenation and can be damaged in that process. Its damage results in lack of energy in a cell, generation of harmful free radicals, oxidative stress and eventually lead to tissue injury.

We are going to investigate the involvement of mitochondria in the processes of hypoxia/reoxygenation by our novel biochemical approach and by advanced non-invasive cellular respirometry techniques for measuring how cells consume oxygen. Also we will be using fluorescent confocal microscopy, special technique to look directly at the different parameters in a single alive cell. Our project will help to develop drugs that can selectively modulate the activity of Complex I in order to lessen tissue damage in brain and heart disorders. In addition it would help us to develop a strategy for early diagnostic and prevention therapy for initial stages of neurodegenerative disorders such as Parkinson?s and specific heritable diseases. Our research will help to develop new drugs that may stop or slow down the death of nerve cells. In addition, knowledge on how hypoxic signals are carried out inside the cell will allow clinicians to suppress growth and invasion of cancer which is often associated with lack of oxygen in the tumour.</gtr:abstractText><gtr:technicalSummary>Mitochondrial complex I plays a critical role in regulating energy generation in cell and it is involved in a number of clinical conditions such as neurodegeneration (Parkinson?s disease, Leber?s optic neuropathy), muscular pathologies and processes of ageing. At the same time ischaemia/reperfusion injury mediated by mitochondria is a major cause of heart diseases, as well as stroke; these two are the leading causes of death in the UK, ranking before cancer and cause more than 30% of deaths. This proposal is aimed at unraveling the role of mitochondrial complex I in such pathological conditions translating new findings to clinical medicine.

Complex I has a high control over the respiration rate and therefore it is likely that the moderate changes in its activity would make a strong effects on the overall rate of oxidative phosphorylation. In addition Complex I is also a source of detrimental free radicals, as well as a target for oxidative damage by them. I intend to clarify the role of Complex I in cellular response to hypoxia and identify possible key points of control of the enzyme my physiological and pharmacological modulators. I propose to investigate Complex I behaviour in detail using classical biochemical as well as novel non-invasive cell-imaging approaches.

Firstly, I will identify structural differences between two Complex I states in isolated mitochondrial membranes from brain and heart, characterise them by cross-linking and amino acid specific covalent reagents. Further I will study Complex I activity and factors influencing it in several cultured cell lines including myocytes and neurons during processes of hypoxia and reoxigenation. I plan to use biochemical and live cell imaging techniques to carry out functional studies of effect of pharmacological agents on Complex I and how they influence cell viability in hypoxia/reoxygenation. The proposed line of research will clarify the physiological and pathophysiological consequences of complex I activity changes and ROS production during hypoxia/reoxygenation and nitric oxide exposure.

Prolonged hypoxia initiates a sequence of cellular responses via the hypoxia-inducible transcription factors (HIFs). It has been proposed that mitochondrial ROS, oxygen redistribution and other transcriptional pathways are involved in HIF-1alpha stabilisation at low oxygen concentrations, but the relative contribution of these mechanisms in hypoxia is not clear. I will therefore also study the involvement of cellular components in accumulation of HIF-1alpha via ROS-dependent and independent mechanisms.

In the proposed project I am going to bring together two essential aspects of hypoxic studies important for development of cardio- and neuroprotective therapy and anticancer interventions. Understanding how and why Complex I activity is modulated in cells will elucidate the role of mitochondria in ischaemic/reoxygenation injury, muscular- and neurodegeneration as well as age-related loss of muscle function. Such understanding could lead to the development of new clinical diagnostic tools and presents opportunities for therapeutic intervention. At the same time unravelling of involvement of respiratory chain in HIF-1alpha stabilisation will help to design strategies for anticancer treatment.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-01-16</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>385894</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nijmegen Centre for Mitochondrial Disorders (NCMD)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Nijmegen Center for Mitochondrial Disorders, Prof. Ulrich Brandt</gtr:description><gtr:id>045B8F57-E0A7-4082-9255-FE8F526925D1</gtr:id><gtr:impact>Map of 2D gels of separated subunits of bovine heart Complex I has been created</gtr:impact><gtr:outcomeId>d2pdAqb8kwZ-1</gtr:outcomeId><gtr:partnerContribution>Identification of bovine Complex I subunits</gtr:partnerContribution><gtr:piContribution>Belfast - crosslinking of mitochondrial complex I and Blue Native Page and doubleSDS PAGE separation of subunits.

Frankfurt - proteomics studies and identification of subunits.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's University Belfast</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine, Dentistry and Biomedical Sciences</gtr:department><gtr:description>QUB, School of Medicine, Dr David Grieve</gtr:description><gtr:id>E7F31D2B-6680-4867-B3E9-4E7E05275C63</gtr:id><gtr:impact>Oxidative damage to cardiac tissues was characterised using obtained samples. Complex I kinetic analysis has been performed. 

Paper has been submitted to Antioxidant and Redox Signalling Journal</gtr:impact><gtr:outcomeId>tE5jEsAr1jr-1</gtr:outcomeId><gtr:partnerContribution>D Grieve - Animal models of ischaemia-reperfusion and tissue samples production</gtr:partnerContribution><gtr:piContribution>A Galkin - analysis of samples obtained from ischaemia/reperfusion animal model</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute for Women's Health</gtr:department><gtr:description>UCL, Nikki Robinson</gtr:description><gtr:id>9B5C4C80-E64E-49C5-A989-CCA312021663</gtr:id><gtr:impact>Identification of primary targets of brain damage in postnatal brain ischaemia and effects of post conditioning</gtr:impact><gtr:outcomeId>545a59c2353f83.98232332-1</gtr:outcomeId><gtr:partnerContribution>Animal model of brain ischaemia in newborn pigs</gtr:partnerContribution><gtr:piContribution>Characterisation of outcome of therapeutic intervention during postnatal brain ischaemia model in newborn pigs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cornell University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Weill Cornell Medicine</gtr:department><gtr:description>Cornell Medical College, Susan Vannucci</gtr:description><gtr:id>4D430257-D920-4AD1-A8CC-31BC3986FFC1</gtr:id><gtr:impact>Physiologically relevant model for studying involvement of mitochondria useful for amelioration of brain oxygen deprivation in newborn infants</gtr:impact><gtr:outcomeId>545a5862909cf0.98183427-1</gtr:outcomeId><gtr:partnerContribution>Rat models of perinatal cerebral hypoxia-ischaemia</gtr:partnerContribution><gtr:piContribution>Analysis of tissue samples obtained by using animal model. Characterisation of tissue injury in perinatal brain ischaemia</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public understanding of Science lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>337A94F6-3457-4781-8280-A41044A75D76</gtr:id><gtr:impact>50 pupils from Downpatrick College attended my talk during Public Science week

http://go.qub.ac.uk/bioenergetics


Students visits and during so-called familarization week have been arranged</gtr:impact><gtr:outcomeId>Aeppck4rAnz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public talk for MitoFamilies Ireland</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B3E8A269-4CFE-44A0-947A-167823987CC7</gtr:id><gtr:impact>It was a public talk for the MitoFamilies society of parents with children affected by mitochondrial disorders.

There was a great deal of talking at this meeting much of it was very emotional since these parents have the first hand experience in mitochondrially associated disease that affected their children. There was a lot of transparency in our discussion. The dialogue was well informed, structured and more inclusive. I think we succeed in creation of a public space for conversation and increment of amount of real information and exchange that led to higher public awareness in biochemical sciences and clinical actions towards mtDNA inherited diseases.</gtr:impact><gtr:outcomeId>545a852b11e8d0.11026025</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.facebook.com/mitofamiliesireland</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Primary Bioscience</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>651BC0BE-08B4-461A-9C94-94A67B3940CD</gtr:id><gtr:impact>Primary BioSciences (PBS), supported by the Wellcome Trust, is a programme to help primary schools achieve relevant aims of the Northern Ireland Curriculum at Key Stage 2, by developing pupils' capabilities related to personal understanding and health, and in the science and technology area of The World Around Us, specifically in the biomedical sciences and bioengineering.

For pupils, the programme ends with a celebration event, where they demonstrate what they have learned about the biosciences. Later, a Primary BioSciences Teaching and Learning Guide will be launched. This will include case studies of successful bioscientist / teacher / pupil interaction, and lesson plans for appropriate bioscience activities for primary pupils. A copy will be provided for each primary school in Northern Ireland. This will be linked to the availability of complementary resources on an appropriate website, including activity sheets, which can be amended to suit individual classes, and links to appropriate external websites.</gtr:impact><gtr:outcomeId>dpp4G9DHSTX</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Annual Northern Ireland Bioscience Olympiad</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>03AA0A6F-DBCD-4DEA-BEB4-E2AB909F1188</gtr:id><gtr:impact>At present, biological education in secondary schools makes biology a collection of facts and answering a question is usually limited to finding the right page in a textbook. The goal of the Bioscience Olympiad is to develop bioscience-oriented &amp;quot;academic thinking&amp;quot; and a creative approach to problem solving in school children. We aim to make the event not a contest of factual knowledge (with questions such as how many vertebras does a frog have or what is the name of an enzyme which cuts proteins) but one of intuitive and creative thinking. Answering the questions requires some basic textbook knowledge, but participants are invited to suggest as many &amp;quot;hypotheses&amp;quot; or &amp;quot;explanations&amp;quot; as they can, invent experiments to test their hypotheses and create a new classification of biological objects/processes (see Examples section).
 
In November 2010 I successfully launched the first pilot Olympiad was in the Medical Biology Building at Queen's University and a team from Antrim Grammar School won the Champions' cup. The contest consisted of a practical with theoretical components where participants had to do some experimental problem solving as well as answer questions.

Unlike many similar contests our Olympiad is not focused on &amp;quot;knowledge-testing,&amp;quot; but rather the provision of alternative ways students to understanding natural sciences for the students. Another main goal is career-guidance for talented and capable school children and improvement of the quality of their education.

The winners of 2012 Olympiad were chosen to represent Republic of Ireland at the International Olympiad in Singapore.

Olympiad was sponsored in part by Biochemical Society and Irish Section of Biochemical Society.



Since 2010, participation in the Olympiad has increased from 7 (2010) to 24 (2014) secondary schools. More school students became aware of biochemical concepts in natural sciences.

We strive to bring science to life and show how science works, to emphasize problem solving aspects and critical thinking in bioscience and the understanding of main biological concepts.

I think we succeeded in developing teamwork and cooperative learning strategies among Northern Ireland secondary school students independent of their religious background.

After our events biological education is more interesting and more students will engage in natural science activities .

I believed that since 2010 we attracted more female students to professional and technical careers in natural sciences.</gtr:impact><gtr:outcomeId>545a5d521fe124.33905091</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.qub.ac.uk/Olympiad</gtr:url><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1260000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC project grant CoInvestigator</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M006743/1</gtr:fundingRef><gtr:id>FBB495ED-79CA-4593-A980-C25EA8AE3105</gtr:id><gtr:outcomeId>545a5c5f17b544.48930164</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>57000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Department for Employment and Learning Northern Ireland (DELNI)</gtr:department><gtr:description>DEL Postgraduate fellowship</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Government of Northern Ireland</gtr:fundingOrg><gtr:id>74B764C8-060E-4492-8702-3E812E84AC32</gtr:id><gtr:outcomeId>geXMemUpAYg</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>380000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC project grant</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L007339/1</gtr:fundingRef><gtr:id>BB7EC242-8FE8-4C17-A8D6-13D289B024DD</gtr:id><gtr:outcomeId>545a5b8d355236.42203626</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7 Travel grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>3E93CC67-8475-468C-ABC9-C3F9A8369CB1</gtr:id><gtr:outcomeId>NY1a2BBomNt</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Map of mitochondrial complex I subunits for enzyme isolated by Blue Native PAGE and double SDS PAGE.</gtr:description><gtr:id>430E3A20-BA73-4BAE-B14A-B08F4A8EC779</gtr:id><gtr:impact>Mass spectrometry analysis of complex I subunits composition will significantly facilitate their identification for other research groups studying mitochondrial bioenergetics, especially in regard to clinical research .</gtr:impact><gtr:outcomeId>puEoPDzNwb2</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Complex I subunits map</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DF1F130E-A1EC-4042-9393-3D44C928E594</gtr:id><gtr:title>ND3, ND1 and 39kDa subunits are more exposed in the de-active form of bovine mitochondrial complex I.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e76d06e88e5aaa999a33e14af9a2abe"><gtr:id>5e76d06e88e5aaa999a33e14af9a2abe</gtr:id><gtr:otherNames>Babot M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>pm_540e179e1797d06a9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1BD0A20-7977-4B8F-94F8-FF288F2CE88F</gtr:id><gtr:title>Isolation and identification of mitochondrial complex I subunits by three-dimensional electrophoresis: Applications</gtr:title><gtr:parentPublicationTitle>Biochimica et Biophysica Acta (BBA) - Bioenergetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e76d06e88e5aaa999a33e14af9a2abe"><gtr:id>5e76d06e88e5aaa999a33e14af9a2abe</gtr:id><gtr:otherNames>Babot M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545a55d413afa7.74616287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF1DAE07-8065-4A04-976C-8A82AFC31377</gtr:id><gtr:title>Molecular mechanism and physiological role of active-deactive transition of mitochondrial complex I.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e76d06e88e5aaa999a33e14af9a2abe"><gtr:id>5e76d06e88e5aaa999a33e14af9a2abe</gtr:id><gtr:otherNames>Babot M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_14156_26_24059527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B477151E-FDBA-4D03-B028-3555B61B5F10</gtr:id><gtr:title>Characterisation of the active/de-active transition of mitochondrial complex I.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e76d06e88e5aaa999a33e14af9a2abe"><gtr:id>5e76d06e88e5aaa999a33e14af9a2abe</gtr:id><gtr:otherNames>Babot M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>pm_540e179e1798706a8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3C2A749-59A9-46D2-9E34-A24E3258B7E4</gtr:id><gtr:title>siRNA technology in kidney transplantation: current status and future potential.</gtr:title><gtr:parentPublicationTitle>BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b928c7339a46dd9972866ca75d2df9b9"><gtr:id>b928c7339a46dd9972866ca75d2df9b9</gtr:id><gtr:otherNames>Glebova K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1173-8804</gtr:issn><gtr:outcomeId>55784d824f3cd8.04899519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56783FBE-731C-4054-A1C4-28770ADBFC6C</gtr:id><gtr:title>Succinate dehydrogenase regulation in normoxic and anoxic conditions in mammal heart and brain</gtr:title><gtr:parentPublicationTitle>Biochimica et Biophysica Acta (BBA) - Bioenergetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e905e1121c994134f147a31290c19566"><gtr:id>e905e1121c994134f147a31290c19566</gtr:id><gtr:otherNames>Labarbuta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545a561db0d491.82364787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A7A9610-8831-4E41-AD75-BC619EB4061B</gtr:id><gtr:title>Conformation-specific crosslinking of mitochondrial complex I.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35b83ada70b9e0aaaca67da686e2222f"><gtr:id>35b83ada70b9e0aaaca67da686e2222f</gtr:id><gtr:otherNames>Ciano M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>pm_14156_26_23454639</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABE32D30-3774-42EE-BC14-81D95E3631E8</gtr:id><gtr:title>Modulation of the conformational state of mitochondrial complex I as a target for therapeutic intervention.</gtr:title><gtr:parentPublicationTitle>Interface focus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f376d441a3e486dedaf3d49c673e0282"><gtr:id>f376d441a3e486dedaf3d49c673e0282</gtr:id><gtr:otherNames>Galkin A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2042-8898</gtr:issn><gtr:outcomeId>58bd674623d4a8.71455999</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A164175-B143-4DAC-B353-238B39142DB9</gtr:id><gtr:title>The Evaluation and Quantitation of Dihydrogen Metabolism Using Deuterium Isotope in Rats.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bf991a96a3305c956f659d117315cdd"><gtr:id>0bf991a96a3305c956f659d117315cdd</gtr:id><gtr:otherNames>Hyspler R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5675e71bc802d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBF9384D-936D-418C-B847-C4120E52492D</gtr:id><gtr:title>Biochemical characterisation of A/D conformational changes of mitochondrial Complex I</gtr:title><gtr:parentPublicationTitle>BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df713d731ddd7251faf0cab84cbfd459"><gtr:id>df713d731ddd7251faf0cab84cbfd459</gtr:id><gtr:otherNames>Birch Amanda</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0005-2728</gtr:issn><gtr:outcomeId>RPBASoJtFBu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D41FBDDA-AB21-4CD0-A9C0-AB4DDA0F3A70</gtr:id><gtr:title>Characterisation of the active/de-active transition of mitochondrial complex I</gtr:title><gtr:parentPublicationTitle>Biochimica et Biophysica Acta (BBA) - Bioenergetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f376d441a3e486dedaf3d49c673e0282"><gtr:id>f376d441a3e486dedaf3d49c673e0282</gtr:id><gtr:otherNames>Galkin A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545a561ddb3f62.06195877</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8A633F1-4265-465B-B088-856C0321D1D4</gtr:id><gtr:title>Conformational change of mitochondrial complex I as a key event in ischaemia/reperfusion damage</gtr:title><gtr:parentPublicationTitle>BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c4e6b175f02d05755be725c6f75e1bb"><gtr:id>5c4e6b175f02d05755be725c6f75e1bb</gtr:id><gtr:otherNames>Gorenkova Natalia</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0005-2728</gtr:issn><gtr:outcomeId>E8a6TX7D8ju</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8AE32FB-F704-4D80-8469-AD6BC77C539A</gtr:id><gtr:title>Effect of monovalent cations on the kinetics of hypoxic conformational change of mitochondrial complex I.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/690172a7b282463c62dacc48142bce5f"><gtr:id>690172a7b282463c62dacc48142bce5f</gtr:id><gtr:otherNames>Stepanova A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>55784d05680df8.57924774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1DA546C-DD94-4E08-896C-E14EE27C0F97</gtr:id><gtr:title>Ischemic A/D transition of mitochondrial complex I and its role in ROS generation.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ce6d2fb68e13155ac2b43a600c6756a"><gtr:id>8ce6d2fb68e13155ac2b43a600c6756a</gtr:id><gtr:otherNames>Dr?se S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>56b0dd409a28d0.78171722</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA1D6710-F5BA-44A3-AE58-2382C6902CF5</gtr:id><gtr:title>Mapping of A/D conformational changes of mitochondrial complex I</gtr:title><gtr:parentPublicationTitle>BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05275a02d47a20a5d0c8b14a2f55fc3c"><gtr:id>05275a02d47a20a5d0c8b14a2f55fc3c</gtr:id><gtr:otherNames>Babot Marion</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0005-2728</gtr:issn><gtr:outcomeId>HeNDNp9nHdV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D3A96BF-AA55-4352-B1B8-BAF8D7FA1DAC</gtr:id><gtr:title>Conformational change of mitochondrial complex I increases ROS sensitivity during ischemia.</gtr:title><gtr:parentPublicationTitle>Antioxidants &amp; redox signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bee28fd3e63a48677516ba5a9e27ecf9"><gtr:id>bee28fd3e63a48677516ba5a9e27ecf9</gtr:id><gtr:otherNames>Gorenkova N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1523-0864</gtr:issn><gtr:outcomeId>Md2KHezdeea</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1100051</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>